Skip to main content

Table 1 Physiologic data during the experiment

From: Lung-protective ventilation increases cerebral metabolism and non-inflammatory brain injury in porcine experimental sepsis

 

Group

0

1

2

3

4

5

6

p

TVe

Low VT

163 ± 16

163 ± 15

163 ± 15

164 ± 15

166 ± 11

165 ± 12

165 ± 11

0.001

 (cmH20)

Medium high VT

244 ± 35

247 ± 37

245 ± 37

248 ± 38

247 ± 37

247 ± 37

247 ± 38

 

RR

Low VT

46 ± 3

46 ± 4

48 ± 5

48 ± 5

48 ± 5

48 ± 5

48 ± 5

0.001

 (min-1)

Medium high VT

24 ± 5

24 ± 5

24 ± 5

24 ± 5

24 ± 5

24 ± 5

24 ± 5

 

P Peak

Low VT

19 ± 2

20 ± 2

20 ± 2

21 ± 1

21 ± 2

21 ± 2

21 ± 2

0.04

(cmH20) 

Medium high VT

21 ± 1

22 ± 1

22 ± 2

22 ± 2

22 ± 2

22 ± 2

23 ± 2

 

Compliance

Low VT

23 ± 8

24 ± 8

22 ± 5

21 ± 6

21 ± 5

21 ± 4

19 ± 3

0.06

(mL x cmH20-1

Medium high VT

30 ± 6

27 ± 8

26 ± 7

26 ± 6

26 ± 5

25 ± 4

24 ± 5

 

PaO2

Low VT

19.0 ± 1.2

15.8 ± 3.1

17.1 ± 2.2

15.3 ± 3.3

15.1 ± 2.9

15.4 ± 2.6

15.1 ± 2.9

0.16

 (kPa)

Medium high VT

19.3 ± 1.5

17.8 ± 2.8

16.5 ± 3.8

16.5 ± 3.8

16.0 ± 3.8

17.7 ± 2.7

17.0 ± 2.3

 

PaCO2

Low VT

5.6 ± 0.4

6.2 ± 0.7

5.6 ± 0.3

5.6 ± 0.4

5.5 ± 0.6

5.3 ± 0.5

5.3 ± 0.5

0.15

(kPa)

Medium high VT

5.1 ± 0.3

5.6 ± 0.5

5.5 ± 0.5

5.5 ± 0.5

5.3 ± 0.3

5.3 ± 0.6

5.2 ± 0.3

 

PaO2/FiO2

Low VT

475 ± 31

395 ± 80

427 ± 55

381 ± 82

373 ± 80

380 ± 74

348 ± 78

0.66

(mmHg) 

Medium high VT

484 ± 38

421 ± 120

404 ± 80

385 ± 76

405 ± 90

410 ± 75

379 ± 89

 

Temp

Low VT

38.1 ± 0.4

38.3 ± 0.6

38.5 ± 0.8

38.8 ± 0.9

38.8 ± 0.9

38.7 ± 1.1

38.7 ± 1.1

0.29

(°)

Medium high VT

38.3 ± 0.8

38.8 ± 1.2

39.2 ± 1.4

39.4 ± 1.6

39.5 ± 1.9

39.5 ± 1.9

39.4 ± 2.1

 

HR

Low VT

95 ± 25

106 ± 21

102 ± 15

111 ± 24

104 ± 18

104 ± 17

105 ± 16

0.45

(min-1

Medium high VT

97 ± 17

110 ± 26

111 ± 21

108 ± 18

110 ± 21

111 ± 21

125 ± 29

 

MAP

Low VT

83 ± 13

83 ± 19

96 ± 13

95 ± 20

92 ± 18

84 ± 19

83 ± 19

0.69

(mmHg)

Medium high VT

89 ± 11

95 ± 18

98 ± 17

98 ± 13

91 ± 19

83 ± 16

77 ± 15

 

MPAP

Low VT

18 ± 3

37 ± 8

31 ± 5

35 ± 9

30 ± 7

28 ± 7

27 ± 7

0.15

(mmHg) 

Medium high VT

19 ± 3

33 ± 9

30 ± 6

29 ± 6

25 ± 4

23 ± 4

24 ± 3

 

ICP

Low VT

12 ± 6

17 ± 6

18 ± 7

21 ± 10

23 ± 9

25 ± 13

26 ± 15

0.72

(mmHg)

Medium high VT

17 ± 12

17 ± 7

19 ± 8

18 ± 6

17 ± 4

16 ± 4

18 ± 5

 

CI

Low VT

3.4 ± 1.2

3.5 ± 1.2

3.2 ± 0.8

2.9 ± 0.9

2.9 ± 0.9

3.1 ± 0.7

3.2 ± 0.8

0.24

 (L x min-1 x m-2)

Medium high VT

3.4 ± 0.5

2.8 ± 0.7

2.6 ± 0.5

2.5 ± 0.6

2.6 ± 0.5

2.8 ± 0.7

2.8 ± 0.6

 

Lactate

Low VT

1.6 ± 0.6

1.5 ± 0.8

1.1 ± 0.5

1.2 ± 0.6

1.3 ± 0.6

1.1 ± 0.4

0.9 ± 0.3

0.95

(mmol x L-1)

Medium high VT

1.4 ± 0.3

1.8 ± 1.3

1.3 ± 0.3

1.3 ± 0.5

1.0 ± 0.3

0.9 ± 0.2

0.9 ± 0.2

 

Diuresis

Low VT

 

40(25–50)

70(38–180)

90(55–170)

111(80–500)

175(60–340)

180(65–390)

0.71

 (mL x h-1)

Medium high VT

 

95(50–160)

105(50–180)

160(80–270)

70(55–180)

90(40–290)

95(40–290)

 
  1. Values are mean ± SE or median (interquartile range). The p-values are results of general linear models with random effects. A p value of < 0.05 was considered significant
  2. TVe expired tidal volume, RR respiratory rate, P Peak peak airway pressure, Compliance-Static airway compliance, PaO2 arterial partial pressure of oxygen, PaCO2 arterial partial pressure of carbon dioxide, PaO2/FiO2 arterial partial pressure of oxygen to fraction of inspired oxygen, Temp core body temperature, HR heart rate, MAP mean arterial pressure, MPAP mean pulmonary arterial pressure, ICP intracranial pressure, CI cardiac index